Back to Search Start Over

Fibromyalgia position paper.

Authors :
Sarzi-Puttini P
Giorgi V
Atzeni F
Gorla R
Kosek E
Choy EH
Bazzichi L
Häuser W
Ablin JN
Aloush V
Buskila D
Amital H
Da Silva JAP
Perrot S
Morlion B
Polati E
Schweiger V
Coaccioli S
Varrassi G
Di Franco M
Torta R
Øien Forseth KM
Mannerkorpi K
Salaffi F
Di Carlo M
Cassisi G
Batticciotto A
Source :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 May-Jun; Vol. 39 Suppl 130 (3), pp. 186-193. Date of Electronic Publication: 2021 May 13.
Publication Year :
2021

Abstract

Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.

Details

Language :
English
ISSN :
0392-856X
Volume :
39 Suppl 130
Issue :
3
Database :
MEDLINE
Journal :
Clinical and experimental rheumatology
Publication Type :
Academic Journal
Accession number :
34001303
Full Text :
https://doi.org/10.55563/clinexprheumatol/i19pig